| Abstract |
【Abstract】 Objective To investigate the effects of early intensive insulin therapy assisted psychological communication on blood glucose control and myocardial function in newly diagnosed type 2 diabetic heart disease with depressive symptoms. Methods From November 2013 to August 2016, selected 72 newly diagnosed type 2 diabetic heart disease with depressive symptoms in qinlong hospital were randomly divided into control group and study group, each group 36 cases. The control group was treated with early insulin intensive therapy and the study group was treated with early intensive insulin therapy assisted psychological communication, the two groups continued to intervene for 3 months. Blood glucose index [fasting blood glucose (FPG), postprandial 2h blood glucose (2hPG)], myocardial function index [left ventricular end-diastolic diameter (LVEDD), left ventricular end-diastolic diameter (LVESD), left ventricular ejection (LVEF)], depression score (HAMD, SDS), quality of life score (DSQL) changes were statistically compared between the two groups at admission and after the intervention. Results After intervention, FPG, 2hPG of the two groups were lower than those before intervention, and the study group was lower than those in the control group, and the difference was statistically significant (P <0.05); There was no significant difference in LVEDD, LVESD and LVEF between the two groups before intervention (P> 0.05), but after intervention, the LVEDD and LVESD in the study group were lower than those in the control group, and LVEF was higher than that of the control group, these differences were statistically significant (P <0.05); The scores of HAMD and SDS in the two groups after intervention were lower than those before intervention, and the study group was lower than those in the control group, and the difference was statistically significant (P <0.05). Conclusion Early insulin intensive therapy assisted psychological communication is helpful to reduce the blood glucose level, improve the myocardial function, relieve bad mood and improve the quality of life in patients with newly diagnosed type 2 diabetic heart disease with depressive symptoms, with worthy of promotion.
|